Scientists at Queen’s University Belfast have discovered a new molecule which has the potential to prolong the life of individuals with cystic fibrosis (CF).
The molecule represents a possible future treatment and works by altering cellular ion channels resulting in improved airway hydration and significantly increased mucus clearance.
For individuals with CF, normal airway clearance mechanisms which keep the lungs free of infection are defective. As a result, a build-up of mucus occurs and predisposes the individual to chronic bacterial infection. The ensuing cycles of chronic infection and airway inflammation cause progressive destruction of the airways, which is ultimately fatal.
The innovative approach could reduce the frequency of these infections through a novel protease inhibitor which prevents activation of the epithelial sodium channel; ENaC.
The research involved a team of scientists from Queen’s University alongside colleagues at the Royal College of Surgeons in Ireland and the University of North Carolina, and was funded by The Cystic Fibrosis Trust.
Speaking about the breakthrough, Dr Lorraine Martin from the School of Pharmacy at Queen’s University Belfast, said: “This is an important finding which could provide a novel therapeutic opportunity relevant to all individuals with CF, as the targeting of ENaC is independent of their underlying CF mutation. This strategy could prevent the significant lung damage that results from chronic cycles of infection and inflammation, with potential impact on quality of life as well as life expectancy. This is a further example of Queen’s University’s research advancing knowledge and changing lives.”
Ed Owen, Chief Executive at the Cystic Fibrosis Trust, said: “We are thrilled with these initial findings and are excited to see how the next stage of preclinical testing progresses. We are pleased to have been able to fund this world class project at its early stage and welcome the drug development programme planned over the coming years. Research is the biggest single area of investment for the Cystic Fibrosis Trust and it’s wonderful to see projects like this making such positive progress in our fight for a life unlimited.”
Currently available pharmacological alternatives are only suitable for a small subset of patients depending on the disease-causing genetic mutation.
The Latest on: Cystic Fibrosis
via Google News
The Latest on: Cystic Fibrosis
- ‘Now’s the time’: Cystic fibrosis community calls for Canada to fast-track ‘miracle’ drugon November 12, 2020 at 3:05 pm
2:08 ‘Miracle’ CF drug one step closer to Canada Members of the cystic fibrosis (CF) community are calling for a drug that’s being described as a life-saving miracle treatment to be fast ...
- Cystic Fibrosis Canada says 'life-changing' drug coming to Canada, but approval months awayon November 11, 2020 at 3:20 pm
For more than a year, Cystic Fibrosis (CF) patients and advocates in Canada have been fighting for access to the 'life-changing' drug Trikafta. 22-year-old Windsorite Aalaya Fleming says the drug ...
- Manufacturer moves to bring 'life-changing' cystic fibrosis drugs to Canadaon November 10, 2020 at 3:35 pm
Mark Lindsay wishes his daughter, Chantelle, were here to see the fruition of her fight to bring transformational new therapies for cystic fibrosis to Canada. But Lindsay knows the 23-year-old, who ...
- Trikafta, cystic fibrosis ‘miracle drug’, one step closer to being approved in Canadaon November 10, 2020 at 1:55 pm
2:04 Quebec patient relieved new cystic fibrosis treatment is coming to Canada Canadians living with cystic fibrosis (CF) are in celebration mode, as what’s been described as a life-saving ...
- Manufacturer moves to bring 'life-changing' cystic fibrosis drugs to Canadaon November 10, 2020 at 1:13 pm
Mark Lindsay wishes his daughter, Chantelle, were here to see the fruition of her fight to bring transformational new therapies for cystic fibrosis to Canada. But Lindsay knows the 23-year-old ...
- Cystic Fibrosis Market Research 2021, Consumption, Companies , Industry Report Analysis and Future Demand By 2026on November 9, 2020 at 3:10 pm
Kenneth Research has recently added a market research study on Cystic Fibrosis Market 2026 which provides a complete comprehensive analysis including the data by Segmentations, by Geography and as ...
- Cystic Fibrosis Market is expected to reach USD 8852.2 million by 2022on November 9, 2020 at 3:10 pm
Cystic fibrosis is a chronic, genetic disease which affects the productivity of the body leading to severe disability ...
- Global Study Reports Updated COVID-19 Outcomes in People With Cystic Fibrosison November 9, 2020 at 6:00 am
Today, the Cystic Fibrosis Registry Global Harmonization Group, including the CF Foundation, published in the Journal of Cystic Fibrosis updated data on the impact of COVID-19 on people with cystic ...
via Bing News